Bruck Kifle

Array ( [id] => 876483 [patent_doc_number] => 07358257 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-15 [patent_title] => 'Platelet ADP receptor inhibitors' [patent_app_type] => utility [patent_app_number] => 11/293026 [patent_app_country] => US [patent_app_date] => 2005-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22535 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/358/07358257.pdf [firstpage_image] =>[orig_patent_app_number] => 11293026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5694972 [patent_doc_number] => 20060155119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Ascomycin crystalline forms and preparation thereof' [patent_app_type] => utility [patent_app_number] => 11/293286 [patent_app_country] => US [patent_app_date] => 2005-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 5595 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20060155119.pdf [firstpage_image] =>[orig_patent_app_number] => 11293286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 243366 [patent_doc_number] => 07589100 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-15 [patent_title] => 'Non-hygroscopic and powdery amorphous pimecrolimus' [patent_app_type] => utility [patent_app_number] => 11/293283 [patent_app_country] => US [patent_app_date] => 2005-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 7140 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/589/07589100.pdf [firstpage_image] =>[orig_patent_app_number] => 11293283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844417 [patent_doc_number] => 20060122168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Malonamide derivatives' [patent_app_type] => utility [patent_app_number] => 11/289176 [patent_app_country] => US [patent_app_date] => 2005-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40508 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122168.pdf [firstpage_image] =>[orig_patent_app_number] => 11289176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 151882 [patent_doc_number] => 07678790 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-16 [patent_title] => 'Platelet ADP receptor inhibitors' [patent_app_type] => utility [patent_app_number] => 11/286259 [patent_app_country] => US [patent_app_date] => 2005-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7688 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/678/07678790.pdf [firstpage_image] =>[orig_patent_app_number] => 11286259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 606514 [patent_doc_number] => 07153879 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-26 [patent_title] => 'Polymorphs of an epothilone analog' [patent_app_type] => utility [patent_app_number] => 11/271456 [patent_app_country] => US [patent_app_date] => 2005-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7561 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/153/07153879.pdf [firstpage_image] =>[orig_patent_app_number] => 11271456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5715617 [patent_doc_number] => 20060078980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Production of polyketides and other natural products' [patent_app_type] => utility [patent_app_number] => 11/269215 [patent_app_country] => US [patent_app_date] => 2005-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 58316 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20060078980.pdf [firstpage_image] =>[orig_patent_app_number] => 11269215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4579510 [patent_doc_number] => 07834001 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-16 [patent_title] => 'Tricyclic guanidine derivatives as sodium-proton exchange inhibitors' [patent_app_type] => utility [patent_app_number] => 11/667583 [patent_app_country] => US [patent_app_date] => 2005-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 98595 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/834/07834001.pdf [firstpage_image] =>[orig_patent_app_number] => 11667583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5649802 [patent_doc_number] => 20060135537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases' [patent_app_type] => utility [patent_app_number] => 11/266935 [patent_app_country] => US [patent_app_date] => 2005-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32676 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135537.pdf [firstpage_image] =>[orig_patent_app_number] => 11266935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5711027 [patent_doc_number] => 20060052372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders' [patent_app_type] => utility [patent_app_number] => 11/265030 [patent_app_country] => US [patent_app_date] => 2005-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6292 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052372.pdf [firstpage_image] =>[orig_patent_app_number] => 11265030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 609770 [patent_doc_number] => 07151174 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-19 [patent_title] => 'Process for making a non-nucleoside HIV-1 reverse transcriptase inhibitor' [patent_app_type] => utility [patent_app_number] => 11/264281 [patent_app_country] => US [patent_app_date] => 2005-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4396 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/151/07151174.pdf [firstpage_image] =>[orig_patent_app_number] => 11264281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7591251 [patent_doc_number] => 07662809 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Tetracyclic indole derivatives as antiviral agents' [patent_app_type] => utility [patent_app_number] => 11/666583 [patent_app_country] => US [patent_app_date] => 2005-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14511 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662809.pdf [firstpage_image] =>[orig_patent_app_number] => 11666583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4752511 [patent_doc_number] => 20080160586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Process for the Purification of Tacrolimus' [patent_app_type] => utility [patent_app_number] => 11/718415 [patent_app_country] => US [patent_app_date] => 2005-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2249 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20080160586.pdf [firstpage_image] =>[orig_patent_app_number] => 11718415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 849214 [patent_doc_number] => 07381732 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-03 [patent_title] => 'Pyrazolobenzamides and derivatives as factor Xa inhibitors' [patent_app_type] => utility [patent_app_number] => 11/256893 [patent_app_country] => US [patent_app_date] => 2005-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56186 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/381/07381732.pdf [firstpage_image] =>[orig_patent_app_number] => 11256893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5716149 [patent_doc_number] => 20060079512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals' [patent_app_type] => utility [patent_app_number] => 11/253658 [patent_app_country] => US [patent_app_date] => 2005-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 34897 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079512.pdf [firstpage_image] =>[orig_patent_app_number] => 11253658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 81823 [patent_doc_number] => 07745427 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'CGRP receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/665943 [patent_app_country] => US [patent_app_date] => 2005-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36942 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745427.pdf [firstpage_image] =>[orig_patent_app_number] => 11665943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92267 [patent_doc_number] => 07732438 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'CGRP receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/665520 [patent_app_country] => US [patent_app_date] => 2005-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17911 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732438.pdf [firstpage_image] =>[orig_patent_app_number] => 11665520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5808352 [patent_doc_number] => 20060094707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Constrained compounds as CGRP-receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/247697 [patent_app_country] => US [patent_app_date] => 2005-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61435 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094707.pdf [firstpage_image] =>[orig_patent_app_number] => 11247697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4922765 [patent_doc_number] => 20080071082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'Heteroatoms-Containing Tricyclic Compounds' [patent_app_type] => utility [patent_app_number] => 11/575757 [patent_app_country] => US [patent_app_date] => 2005-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2188 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20080071082.pdf [firstpage_image] =>[orig_patent_app_number] => 11575757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 173885 [patent_doc_number] => 07659264 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-09 [patent_title] => 'CGRP receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/664905 [patent_app_country] => US [patent_app_date] => 2005-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22418 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/659/07659264.pdf [firstpage_image] =>[orig_patent_app_number] => 11664905 [rel_patent_id] =>[rel_patent_doc_number] =>)